Journal of Surgery

There is a dearth of information regarding surgical services and patient outcomes during a pandemic because the major focus is kept on the pandemic itself and critical care. The majority of the small studies focusing on the outcomes of Covid-19 positive patients after various surgical procedures, such as thoracic and orthopaedic surgery, make up the currently available Covid-19 evidence. According to these preliminary investigations, surgery increases the chance of death in people who have Covid-19 and the disease's progression in those who are only incubating it. More recently, the COVIDSurg partnership has reported on 1128 surgical patients with a Covid-19 diagnosis (pre- or post-surgery) across 235 hospitals in 24 countries with a variety of therapeutic indications.

Surgery patients who are on dialysis are in a high-risk category. The results of major thoracic surgical procedures in dialysis patients have only been studied in a small number of studies. In patients receiving haemodialysis, we assessed the results of pulmonary resection for non-small cell lung cancer .Surgery involving dialysis patients is a high-risk situation that calls for meticulous postoperative management. Patients on dialysis are frequently not deemed eligible for major surgical procedures due to their higher risk of perioperative problems linked with electrolyte imbalance, haemorrhage, infection, and hemodynamic instability. Due to this, only a small number of studies have assessed the results of major thoracic surgical procedures in patients who are receiving dialysis for chronic kidney disease .This study's objective was to assess the postoperative results of pulmonary resection for non-small cell lung cancer in patients who are receiving haemodialysis because of chronic kidney disease in terms of complications and survival.